United States · Growth startup
Funding summaryUpdated 26 Oct 2026
$138Mraised across 6 rounds since 2006, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Reported by sec.govSEC filing: $6.0M sold, first sale Dec 2012
No investor was named in the report.
Reported by sec.govSEC filing: $6.0M sold, first sale Oct 2011
No investor was named in the report.
Reported by sec.govSEC filing: $27M sold, first sale Sept 2009
InterWest Partners
Sofinnova Investments
Prospect Venture Partners
Panorama Capital
Black River Asset ManagementReported by deals.venturebeat.comSEC filing: $8.5M sold, first sale Sept 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Sofinnova InvestmentsProspect Venture PartnersInterWest PartnersFlagship Pioneering, LLC
AbbViePanorama CapitalBlack River Asset ManagementMissing a round, or an investor who was in one? Tell us.
Alvine Pharmaceuticals's investors include Sofinnova Investments, Prospect Venture Partners, InterWest Partners, Flagship Pioneering, LLC and AbbVie, and 2 more on record.
Alvine Pharmaceuticals has raised $138M across 6 rounds since 2006.
Alvine Pharmaceuticals's most recent round was a Growth of $70M in May 2013.
Its most recent round, $70M in May 2013, is also its largest on record.
Alvine Pharmaceuticals's first round on record, in Sept 2006, was backed by Sofinnova Investments and Prospect Venture Partners.
Alvine Pharmaceuticals's latest named round is a Growth, in May 2013.
Alvine Pharmaceuticals is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
